SCHEMBL3434547

SCHEMBL3434547

C=C=C=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2266 0.72
SCHEMBL14650829 0.71
SCHEMBL3260553 0.67
Hydrochloric Acid SCHEMBL4353627 0.67
Ammonia Solution, Strong SCHEMBL9986206 0.67
Water SCHEMBL1082819 0.67
SCHEMBL19511604 0.67
Ammonia Solution, Strong SCHEMBL3463589 0.67
Hydrochloric Acid SCHEMBL17284769 0.67
Bromide SCHEMBL22770456 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8361220-B2 Strength improvement admixture CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2013-01-29 US claimed
US-20120298013-A1 Strength Improvement Admixture CONSTRUCTION RESEARCH & TECHNOLOGY GMBH 2012-11-29 US claimed
US-20020107310-A1 Solubilized defoamers for cementitious compositions CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2002-08-08 US claimed
CN-112778186-B Synthetic method of pyrrole compound 西南大学 2022-05-31 CN disclosed
US-9138490-B2 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics THE TEXAS A&M UNIVERSITY SYSTEM (US) 2015-09-22 US disclosed
WO-2015116886-A1 MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-08-06 WO disclosed
US-8394191-B2 Additive capable of undergoing shear thinning in response to the application of energy and recovering viscosity in the absence of an application of energy and an additive that does not undergo shear thinning when used alone in response to the application of energy; reduce the yield stress CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2013-03-12 US disclosed
US-8361220-B2 Strength improvement admixture CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2013-01-29 US disclosed
US-20120298013-A1 Strength Improvement Admixture CONSTRUCTION RESEARCH & TECHNOLOGY GMBH 2012-11-29 US disclosed
US-8288530-B2 Method of preparing macromolecular contrast agents and uses thereof THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-10-16 US disclosed
US-7718721-B2 Poly(arylene ether)/polyolefin composition, method, and article SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-05-18 US disclosed
US-6569924-B2 Mixing cement, water, a water insoluble defoamer, a dispersant for cementitious compositions, and a solubilizing agent that solubilizes the water insoluble defoamer. MBT HOLDINGAG (CH) 2003-05-27 US disclosed
WO-2002078714-A1 FORMULATIONS WHICH ARE RESISTANT TO GASTRIC JUICE AND ARE USED TO APPLY ANTI-INFECTIVE COMPOUNDS INHIBITING THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND THE SALTS AND ESTERS OF THE SAME JOMAA PHARMAKA GMBH (DE) 2002-10-10 WO disclosed
US-20020107310-A1 Solubilized defoamers for cementitious compositions CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2002-08-08 US disclosed
CN-1348374-A Combination preparation of anti-infective active compounds inhibiting the 2-C-methylerythrose-4 metabolic pathway and lipid metabolism inhibitors JOMAA HASSAN (DE) 2002-05-08 CN disclosed
EP-1100510-A2 COMBINED PREPARATION OF ANTI-INFECTIOUSLY ACTIVE COMPOUNDS WHICH INHIBIT THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND INHIBITORS OF LIPID METABOLISM Jomaa, Hassan (DE) 2001-05-23 EP disclosed
WO-1999066875-A2 COMBINED PREPARATION OF ANTI-INFECTIOUSLY ACTIVE COMPOUNDS WHICH INHIBIT THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND INHIBITORS OF LIPID METABOLISM JOMAA HASSAN (DE) 1999-12-29 WO disclosed
US-5782908-A SURFACE TREATING WITH A VINYLSILANETRIOL OR -TRIHALIDE FOLLOWED BY A GRAFT POLYMER TO FORM AN ADHERENT COATING TO WHICH A DRUG, E.G. HEPARIN, OR BIOMOLECULE IS ATTACHED; STENTS; CATHETERS MEDTRONIC, INC. (US) 1998-07-21 US disclosed
EP-0557497-A1 NEW $g(b)-CARBOLIN DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1993-09-01 EP disclosed
WO-1993006100-A1 NEW β-CARBOLIN DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1993-04-01 WO disclosed